U.S. Oil and Gas Stock News

Biglari Holdings (BH.A) has wrapped up FY 2025 with fourth quarter revenue of US$99.9 million and a basic EPS loss of US$193.44, while trailing twelve month revenue came in at US$395.3 million alongside a basic EPS loss of US$143.86. Over recent quarters the company has seen revenue move from US$91.1 million in Q4 2024 to around US$100.6 million at its Q2 2025 peak. EPS has swung between a gain of US$194.57 and losses including US$37.56 and US$126.40, setting up a choppy earnings profile that...

What TWFG’s Recent Share Moves Signal for Investors TWFG (TWFG) has drawn investor attention after recent share price moves, with the stock showing mixed short term performance, modest gains over the past month, but a sharper decline over the past 3 months and year. See our latest analysis for TWFG. At a share price of $19.35, TWFG’s recent 1 day and 7 day share price returns have been positive, but the 90 day share price return and 1 year total shareholder return both point to fading...

JFrog (FROG) has wrapped up FY 2025 with Q4 revenue of US$145.3 million, a basic EPS loss of US$0.13 and net income loss of US$15.2 million, setting the tone for how investors assess its path toward profitability. The company has seen quarterly revenue move from US$109.1 million in Q3 2024 to US$145.3 million in Q4 2025, while basic EPS over the same stretch ranged from a loss of US$0.21 to a loss of US$0.13, keeping the focus squarely on how efficiently that top line converts into earnings...

Why the MicroVision and Avular partnership matters for MVIS stock MicroVision (MVIS) recently signed a Memorandum of Understanding with Avular Innovations to combine its lidar and perception software with Avular’s modular drone platforms, targeting commercial uses such as civil infrastructure inspections and public safety. See our latest analysis for MicroVision. Despite the Avular agreement and an upcoming first quarter 2026 update, MicroVision’s share price sits at US$0.62 after a 6% 1-day...

If you are wondering whether Helmerich & Payne at around US$36.90 is still offering value after a strong run, this breakdown will help you see how the current price stacks up against several valuation checks. The stock has had a mixed short term, with an 8.6% decline over the last 7 days, a 2.8% gain over the past 30 days, and returns of 23.2% year to date and 110.2% over the last year. Recent coverage has focused on Helmerich & Payne in the context of ongoing interest in energy services...

MSA Safety (NYSE:MSA) has signed a definitive agreement to acquire Norway based Autronica Fire & Security. The deal values Autronica at about $550–$555 million. The acquisition adds depth in fire and gas detection for petrochemical, oil and gas, maritime, and wider industrial markets. For investors tracking NYSE:MSA, this move comes with the stock around $171.9 and a value score of 4, alongside a 10.5% return over the past year and 25.6% over three years. The company has also posted a 6.0%...

Rockwell Automation (NYSE:ROK) is showcasing its digital twin and virtualized manufacturing solutions at Interpack 2026. The company is working with major OEMs to present unified, data-enabled food and beverage production lines. The focus is on end to end digital manufacturing with scalability, interoperability, and layered cybersecurity at the core. For investors watching NYSE:ROK, this Interpack 2026 push comes as the stock trades at around $448.55 and has seen a 56.4% return over the...

This article examines whether Norwegian Cruise Line Holdings, at around US$17.22, may currently represent a bargain or a value trap by exploring what the market price could be implying about the stock. The share price has slipped about 5.3% over the last week, 8.1% over the last month and 24.4% year to date, while the 3-year return is 26.1% and the 1-year return is a 3.7% decline. Recent headlines around the cruise industry have focused on changing travel demand, ongoing capacity...

Virtu Financial (NYSE:VIRT) has joined zerohash's liquidity ecosystem as a market-making partner. The company is providing liquidity across zerohash's central limit order book and request for quote systems. The move connects Virtu's market-making capabilities with a growing digital asset infrastructure provider. For you as an investor, this move ties a traditional electronic market maker directly into a digital asset venue. Virtu Financial focuses on market making and trade execution across...

Hope Bancorp (HOPE) drew fresh attention after its Q1 2026 report showed year-over-year growth in revenue and net income, supported by the integration of Territorial Bancorp, higher fee income, and ongoing share repurchases. See our latest analysis for Hope Bancorp. At a share price of US$12.52, HOPE has logged a 14.03% year to date share price return and a 28.10% total shareholder return over the past year. This suggests momentum has been building as investors weigh Q1 earnings, higher net...

If you are wondering whether F&G Annuities & Life is attractively priced or just looks cheap on the surface, its recent share performance gives a few clues worth unpacking. The stock last closed at US$27.08, with a 10.1% gain over the past month but a 9.0% decline over the last year and a 9.9% decline year to date, which may leave you questioning whether sentiment or fundamentals are in the driving seat. Recent coverage of F&G Annuities & Life has focused on its position as a listed insurer...

Plains GP Holdings FY 2025 earnings recap Plains GP Holdings (PAGP) has just wrapped up FY 2025 with fourth quarter revenue of US$10.6 billion and a basic EPS loss of US$0.20, as investors weigh these headline figures against a current share price of US$23.63. Over recent quarters the company has seen revenue move between US$10.6 billion and US$12.5 billion. Basic EPS has ranged from a loss of US$0.44 in late 2024 to a small profit of US$0.04 in Q3 2025. This sets the stage for a close look...

If you are wondering whether Amdocs stock is starting to look like value or a value trap, the current share price puts that question front and center. The stock closed at US$65.14 recently, with returns of 0.7% over 7 days, a 1.9% decline over 30 days, an 18.7% decline year to date and a 27.6% decline over the last year. This naturally raises questions about how the market is reassessing both growth potential and risk. Recent coverage has focused on how Amdocs fits into broader shifts in...

Kenvue (NYSE:KVUE) is progressing toward a pending US$40b acquisition by Kimberly-Clark. Shareholders and major U.S. antitrust authorities have given their approvals. The company is pursuing its 2026 Restructuring Initiative alongside the transaction process. Kenvue, a consumer health company, is at the center of one of the larger proposed deals in its sector, with a pending US$40b acquisition by Kimberly-Clark. With shareholder and key U.S. antitrust approvals already in place, investors...

In early May 2026, General Mills promoted longtime executive Dana McNabb to Chief Operating Officer and board member, expanding her remit to all global operating segments and key functions including supply chain, innovation, and digital. This leadership shift, paired with refreshed incentives for top executives, highlights General Mills’ push to tighten execution, accelerate innovation, and reinforce long-term management continuity. We’ll now examine how McNabb’s expanded operational control...

In late April 2026, Floor & Decor Holdings, Inc. outlined fiscal 2026 earnings guidance, reported softer first‑quarter results, announced plans to open 20 new warehouse stores, and authorized a US$400 million share repurchase program without an expiration date. Taken together, these updates highlight a company balancing continued store expansion with shareholder returns, while signaling its view of long‑term demand for hard‑surface flooring in the United States. Next, we’ll examine how the...

Wondering whether HubSpot at around US$243.72 is a bargain or a value trap? This article walks through what the current share price might be implying about the stock's worth. The stock has moved 9.9% over the last 7 days and 7.1% over the last 30 days, yet the return over the last year sits at a 63.1% decline and the year to date return is a 36.2% decline. Recent coverage has focused on HubSpot's position in marketing and sales software and how investors are reassessing growth stocks with...

Wondering if Adecoagro's recent share price puts it at a bargain or already reflects its strengths? This article breaks down what the current valuation is really telling you. The stock last closed at US$13.37, with a 72.3% return year to date and a 59.0% return over the past year. This is set against shorter term pullbacks of 5.1% over 7 days and 11.0% over 30 days that may signal shifting sentiment around risk and reward. Recent news around global food supply resilience, agricultural input...

Hawaiian Electric Industries (HE) has reported fourth quarter FY 2025 revenue of US$805.8 million and basic EPS of US$0.23, rounding out a trailing twelve month EPS of US$0.71 on revenue of about US$3.1 billion. The company has seen quarterly revenue move from US$799.2 million and EPS of US$0.17 in Q4 2024 to US$805.8 million and EPS of US$0.23 in Q4 2025. Over the same period, the trailing twelve month line has shifted from revenue of US$3.2 billion and EPS of a US$10.42 loss in Q4 2024 to...

If you are wondering whether MaxLinear's recent share price move has left the stock looking expensive or still potentially interesting, the valuation story is where your attention should be. The stock last closed at US$82.37, with returns of 16.4% over 7 days, 347.4% over 30 days, 345.0% year to date and a very large 1 year gain that is more than 6x. These moves sit against a backdrop of ongoing interest in semiconductor stocks, with investors watching closely for updates on demand for...

Alamar Biosciences (NasdaqGS:ALMR) doubled its revenue in Q1 2026. The company launched two new products aimed at neurodegenerative disease research. Alamar completed an IPO in 2026 to support its next phase of growth. Alamar Biosciences operates in the life sciences tools and diagnostics space, where demand for more precise protein and biomarker measurement has been a key theme for researchers and drug developers. The new products focused on neurodegenerative disease research sit in an...

Why the upcoming TN-401 data matters for Tenaya Therapeutics stock Tenaya Therapeutics (TNYA) is drawing attention as investors look ahead to new clinical safety and efficacy data for TN-401, its gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, at the ASGCT 2026 meeting. This late breaking oral presentation, together with additional abstracts on Tenaya’s gene therapy and gene editing programs, gives you fresh information to evaluate the company’s pipeline...

Brixmor Property Group Inc. recently reported first-quarter 2026 results showing year-on-year growth in revenue to US$354.82 million and net income to US$127.75 million, while also updating full-year guidance to net income of US$355 million to US$365 million and diluted EPS of US$1.16 to US$1.19. Alongside the earnings update, the board affirmed a quarterly dividend of US$0.3075 per share and highlighted that 2026 uncollectible revenues are expected to remain contained at 75 to 100 basis...

Sarepta Therapeutics (NasdaqGS:SRPT) is progressing its small interfering RNA (siRNA) candidates SRP-1001 and SRP-1003, with early data viewed as encouraging. The company is seeking to transition AMONDYS 45 and VYONDYS from accelerated to traditional FDA approvals through recent regulatory submissions. These updates come as Sarepta refines its commercial focus beyond gene therapy Elevidys, which continues to face regulatory and commercial complexity. Sarepta Therapeutics focuses on rare...